According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

“Some gene therapy products are also in the clinical trial phase,” IRNA quoted the FDA director, Mehdi Pirsalehi, as saying. Referring to the country’s scientific progress in the pharmaceutical sector ...

Cell therapy is a field rife with innovation ... “We know that these products, the approved products, cost hundreds of thousands of dollars to make and administer,” he said.

the first-ever approval for a mesenchymal stromal cell (MSC) therapy in the US. The regulator has cleared Ryoncil (remestemcel-L) to treat steroid-refractory acute GVHD in paediatric patients aged ...

Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...

Jan. 30, 2025 — A new study has highlighted the potential of resveratrol, a natural compound found in grapes, blueberries, and raspberries, to enhance female fertility. The systematic review ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

coli, the presence of certain group VIIIb transition metal compounds in concentrations of about 1–10 parts per million of the metal in the culture medium causes an inhibition of the cell ...

NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

Although CAR T cell therapy for B cell-driven refractory autoimmune diseases is still in its infancy, these early clinical results show promises for patients. Therefore, it is likely that CAR T cell ...